ACM
INBS icon

Altium Capital Management’s Intelligent Bio Solutions INBS Stock Holding History

Altium Capital Management’s Portfolio INBS Stock Details INBS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-14,925
Closed -$215K – 6
2025
Q1 		$215K Buy
+14,925
New +$278K 0.52% 19
2024
Q3 		– Sell
-8,391
Closed -$161K – 90
2024
Q2 		$161K Buy
+8,391
New +$215K 0.07% 45

Other funds holding INBS

Alyeska Investment Group
Alyeska Investment Group Chicago, Illinois $38.9B AUM 28.51% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
NS
NBC Securities Birmingham, Alabama $1.48B AUM 31.07% 1-Year Est. Return
National Bank of Canada
National Bank of Canada Montreal, Quebec, Canada $140B AUM 46.34% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Altium Capital Management's INBS Position: Q2 2025 in Review

Altium Capital Management sold out of Intelligent Bio Solutions (INBS) in Q2 2025, closing a stake of 14,925 shares — an estimated $215K sold.

Altium Capital Management first reported a position in INBS in Q2 2024 and held it in 2 quarters. The position peaked at $215K in Q1 2025. 9 funds tracked by Wall St. Rank hold INBS as of Q2 2025.

  • Altium Capital Management reported no remaining Intelligent Bio Solutions position as of Q2 2025 after selling out during the quarter.
  • Altium Capital Management sold 14,925 Intelligent Bio Solutions shares in Q2 2025, an estimated $215K.
  • Altium Capital Management first reported a position in Intelligent Bio Solutions in Q2 2024 and held it in 2 quarters.
  • Altium Capital Management's Intelligent Bio Solutions position peaked at $215K in Q1 2025.
  • 9 funds tracked by Wall St. Rank held Intelligent Bio Solutions as of Q2 2025.

Based on Altium Capital Management's 13F filing for Q2 2025.